IDH2 and breast carcinoma: In addition, breast cancer patients with high IDH2 levels had a worse prognosis in overall survival (OS) (Additional file 6E), recurrence free survival (RFS) (Additional file 6F), and distant metastasis-free survival (DMFS) (Additional file 6G).